Dextromethorphan Hydrobromide; Quinidine Sulfate Patent Expiration
Dextromethorphan Hydrobromide; Quinidine Sulfate is Used for managing symptoms of pseudobulbar affect. It was first introduced by Avanir Pharmaceuticals Inc
Dextromethorphan Hydrobromide; Quinidine Sulfate Patents
Given below is the list of patents protecting Dextromethorphan Hydrobromide; Quinidine Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nuedexta | US7659282 | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | Aug 13, 2026 | Avanir Pharms |
| Nuedexta | US8227484 | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
Jul 17, 2023
(Expired) | Avanir Pharms |
| Nuedexta | USRE38115 | Dextromethorphan and an oxidase inhibitor for treating intractable conditions |
Jan 26, 2016
(Expired) | Avanir Pharms |
Dextromethorphan Hydrobromide; Quinidine Sulfate's Family Patents
Explore Our Curated Drug Screens
Dextromethorphan Hydrobromide; Quinidine Sulfate Generic API Manufacturers
Several generic applications have been filed for Dextromethorphan Hydrobromide; Quinidine Sulfate. The first generic version for Dextromethorphan Hydrobromide; Quinidine Sulfate was by Actavis Elizabeth Llc and was approved on Oct 10, 2017. And the latest generic version is by Hetero Labs Ltd Unit Iii and was approved on Aug 28, 2024.
Given below is the list of companies who have filed for Dextromethorphan Hydrobromide; Quinidine Sulfate generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 1 generic for Dextromethorphan Hydrobromide; Quinidine Sulfate. This 20mg;10mg version comes by the name DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG; 10MG | capsule | Prescription | ORAL | AB | Oct 10, 2017 |
Manufacturing Plant Locations New
Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
2. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 1 generic for Dextromethorphan Hydrobromide; Quinidine Sulfate. This 20mg;10mg version comes by the name DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG; 10MG | capsule | Prescription | ORAL | AB | Aug 28, 2024 |